Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.400 -0.130 (-1.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $0.99, below expectations. The company revised its 2024 revenue guidance to... 
Via Benzinga
Exposures COVID-19
NVAX Stock Earnings: Novavax Misses EPS, Beats Revenue for Q2 2024
NVAX stock results show that Novavax missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2. 
Via Talk Markets
Where Will Novavax Be in 5 Years?
Its been a good year so far for the biotech, but how long can it keep the momentum going? 
Via The Motley Fool
What's Going On With Novavax (NVAX) Stock?
Novavax shares are trading lower by 5.5% Thursday morning. Shares of several vaccine makers are trading lower after Moderna revised its 2024 expectations. 
Via Benzinga
Market Whales and Their Recent Bets on NVAX Options
Via Benzinga
What's Going On With Novavax Shares Today?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday. Here's what you need to know. 
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In Novavax 5 Years Ago Would Be Worth Today
Via Benzinga
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
Moderna delivered nearly double the sales analysts expected in the second quarter. 
Via Investor's Business Daily
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
Analysts from JPMorgan Chase have expressed their concern about the outlook for these stocks with lowered price targets. 
Via InvestorPlace
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns. 
Via InvestorPlace
Stocks Mixed After Job Openings, Consumer Data
Stocks are mixed midday, as the Federal Reserve's two-day policy meeting gets underway, with plenty of earnings and economic data for Wall Street to unpack in the meantime. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
It was another wild week for the market as it had to contend with a lot of news. 
Via Talk Markets
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept. 
Via Benzinga
Exposures COVID-19
The Lazarus Effect: 3 ‘Dead’ Stocks That Could Rise From the Ashes
These companies, thought dead, could pull a Lazarus and rise from the ashes, making them stocks to buy for a comeback. 
Via InvestorPlace
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
What's Going On With Novavax Shares Monday?
Novavax, Inc. (NASDAQ: NVAX) shares are moving higher on Monday. Here's what you need to know. 
Via Benzinga
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock. 
Via InvestorPlace
Exposures COVID-19
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trading SMID Biotech Stocks In A Volatile Market
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
Via Talk Markets
Where Will Novavax Be in 1 Year?
We will know a lot more about the vaccine maker's long-term prospects in 12 months. 
Via The Motley Fool
Meme Stock or Vaccine Stock? Novavax’s Identity Crisis and Why It Matters for Investors
It's good news for Novavax that the FDA is targeting a particular Covid-19 strain, but Novavax stock is still to pricey to buy now. 
Via InvestorPlace
Exposures COVID-19 Product Safety
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.